Recovering incidence from repeated measures of prevalence: the case of urinary tract infections.

Journal of Clinical Monitoring and Computing
Francesco SalvaraniCristina Montomoli

Abstract

To study the relationships between prevalence and incidence in the case of nosocomial infections of the urinary tract, and to evaluate if repeated prevalence measures may be useful to obtain an estimate of incidence. Methodology is based on a simple and reasonable assumption on the infection dynamics: starting from a difference equation modeling the evolution of hospital population, it is obtained a set of equations allowing to calculate the incidence by means of the knowledge of prevalence. The numerical validation of the model done by computer simulations, shows that the model obtains a better estimate of incidence than the approach given by the classical rule prevalence = incidence x duration. The proposed strategy permits to forecast the incidence of the urinary tract nosocomial infections by using repeated measures of prevalence. It is hence possible to estimate the incidence from cross-sectional prevalence data with sufficient accuracy to monitor and estimate the time dynamics of these infections.

References

Feb 1, 1989·American Journal of Epidemiology·S C Newman, R C Bland
Jan 1, 1981·American Journal of Epidemiology·F S Rhame, W D Sudderth
May 1, 1993·American Journal of Epidemiology·A E Ades, D J Nokes
Jan 1, 1996·Lifetime Data Analysis·N KeidingG Hasibeder

❮ Previous
Next ❯

Citations

Mar 20, 2018·Neuroepidemiology·Devender BhallaKurosh Gharagozli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.